Pharmaceuticals

J&J told to stop using its baby powder raw material in India

21 Dec 2018

Reports quoting an unnamed senior CDSCO official said on Thursday that Johnson & Johnson has been served with a written order to stop using the "huge quantities" of raw materials stocked in its plants in India

Indian drug regulator may revive probe to J&J’s baby powder: Reuters

18 Dec 2018

Novartis to acquire US cancer drugs maker Endocyte for $2.1 billion

19 Oct 2018

Medical stores protest plans to regularise e-pharmacies

28 Sep 2018

Health ministry bans 328 fixed dose combination drugs

12 Sep 2018

J&J says will work with Indian govt on compensation for defective hip implants

07 Sep 2018

Aurobindo to buy Sandoz’s dermatology business in US for $1 bn

07 Sep 2018

Aurobindo will pay $900 million for about 300 products, three manufacturing facilities in the US and Eon Labs Inc, a wholly owned unit of Sandoz Inc, besides performance-based payments of $100 million on products in the pipeline